The review, conducted according to PRISMA guidelines and operationalised through an explicit PICOS framework, searched five databases, PubMed, Scopus, Web of Science, Dialnet and PsycINFO, for publications from 2013 to 2023. Two reviewers independently screened records at the title and abstract stages and again at full text, resolving disagreements through discussion until consensus was reached. Because AGI does not yet exist as a clinically deployable technology, the eligible literature is overwhelmingly theoretical, ethical or conceptual rather than experimental. The authors therefore adopted an explicit hierarchy-of-evidence framework that distinguishes empirical studies, secondary reviews, ethical and normative analyses, and theoretical or speculative work, weighting the synthesis accordingly. Of 72 records initially identified, 45 studies met the inclusion criteria and were synthesised thematically using NVivo software, with methodological quality appraised through author-developed criteria aligned with the SANRA scale for narrative reviews and the AACODS checklist for non-empirical sources.

The first major theme concerns diagnosis and treatment. AGI-adjacent systems, particularly large language models and multimodal architectures already deployed under the umbrella of narrow AI, have demonstrated genuine potential to support mental health assessment by integrating heterogeneous data streams: clinical notes, speech patterns, facial expression analysis, behavioural telemetry and self-reported symptoms. Conversational interfaces accessible around the clock and at negligible marginal cost could reduce stigma by offering an anonymous, judgement-free first point of contact for people reluctant to seek human help. For underserved regions where the ratio of mental health professionals to population is dangerously low, the prospect of near-universal access to competent psychological support is the review’s most compelling promised benefit.

Yet the same technical capabilities carry the mirror-image risks. The literature consistently warns, at the level of ethical and normative analysis, that automated emotional crisis management is fraught with danger: a system that handles a suicidal disclosure with a plausible but subtly wrong response could produce diagnostic error, false reassurance or lethal delay in escalation to human clinicians. The review stresses that such risks, documented for narrow AI in embryonic form, would be substantially amplified in any future AGI system, and that presentations involving psychosis and other severe mental illnesses pose particular challenges, because the conversational fluency of advanced models can mask a fundamental lack of clinical understanding and may even reinforce delusional content.

The second theme addresses governance. The review identifies emerging regulatory instruments, mandatory algorithmic audits, transnational data protection policies and clearer allocation of medico-legal accountability, as necessary preconditions for any safe integration of AGI into mental health care. Algorithmic audits would function as a technical safeguard, probing systems for bias, brittleness and unsafe behaviour before and during deployment, while data protection frameworks would govern the extraordinarily sensitive information that mental health applications inevitably collect. Accountability remains perhaps the thorniest question: when an autonomous-sounding system contributes to a harmful clinical outcome, the chain of responsibility spanning developers, deployers, clinicians and institutions must be legally defined in advance rather than litigated after tragedy.

The third and most philosophically provocative theme concerns human identity. Drawing on established work-identity and AI ethics literatures, the authors advance theoretical constructs such as ‘existential delaborisation’, the psychological dislocation that could follow if AGI displaces human beings from work that confers meaning, purpose and social standing. They also describe the algorithmic reconfiguration of biographical narratives: the possibility that AGI systems, by curating recommendations, memories and self-reflections, could subtly rewrite the stories people tell about themselves. These phenomena are presented explicitly as theoretical frameworks rather than empirically documented outcomes, but their implications intersect with well-established knowledge that unemployment, loss of occupational identity and social dislocation are robust predictors of depression, anxiety and substance misuse. Mass technological unemployment, should AGI fulfil the most aggressive projections, would therefore constitute not merely an economic problem but a population-scale mental health exposure.

The review also highlights the risk that biases embedded in training data could be perpetuated and amplified within therapeutic interventions. If the corpora on which AGI systems are trained under-represent certain cultures, languages, genders or diagnostic populations, the resulting systems may misinterpret idioms of distress, apply inappropriate diagnostic framings or deliver interventions calibrated to populations unlike the user. Because mental health care depends on trust, cultural sensitivity and nuanced understanding of individual context, such biases are not simply statistical inaccuracies but potential sources of harm and of widening inequity between well-served and marginalised communities.

What distinguishes this analysis from much of the public AGI debate is its disciplined separation of evidence from speculation. The empirical claims about diagnostic support and stigma reduction rest on studies of currently deployed narrow AI, while the warnings about existential and identity-level harms are clearly flagged as normative and theoretical extrapolation. This evidentiary transparency matters practically as well as intellectually: policymakers and clinicians reading the review can see precisely which conclusions are grounded in observed outcomes and which are reasoned projections, allowing proportionate rather than panicked or complacent responses. The authors argue that this evidence-differentiated approach should itself become a standard feature of AI-in-health governance, ensuring that regulatory urgency is matched to evidentiary strength.

The paper’s conclusion is deliberately double-edged. AGI integration in mental health offers the genuine possibility of democratised psychological care, extending support to billions of people who currently have none, while simultaneously posing clinical-safety and existential challenges that demand urgent ethical governance. Success, the authors contend, depends on regulatory frameworks that prioritise transparency, equity, accountability and privacy, and, crucially, on the preservation of authentic human connection as the irreplaceable core of mental health care. Machines may eventually match or exceed human clinicians in informational processing, but the therapeutic alliance, the felt experience of being understood by another conscious being, remains, on the current evidence, a uniquely human asset. Whether AGI arrives by 2030 or decades later, the review’s central message is that the window for building the ethical, legal and clinical infrastructure to receive it safely is open now, and it should not be allowed to close.

Subject of Research: The impact of artificial general intelligence on mental health

Article Title: The impact of artificial general intelligence on mental health (a systematic narrative review)

Article References: Moya, C. C., & Rodríguez, E. Q. (2026). The impact of artificial general intelligence on mental health (a systematic narrative review). Discover Mental Health. https://doi.org/10.1007/s44192-026-00589-z

Image Credits: AI Generated

DOI: 10.1007/s44192-026-00589-z

Keywords: artificial general intelligence, mental health, systematic narrative review, AI ethics, algorithmic bias, digital rights, AI-driven psychotherapy, human identity, evidence hierarchy, medico-legal accountability, algorithmic audits, existential delaborisation

Historically, nonoperative management has gained popularity as a less invasive option aimed at reducing immediate surgical risks and promoting patient comfort. However, this meta-analysis challenges the adequacy of such an approach by consolidating data from multiple clinical trials and observational studies. By scrutinizing endpoints such as treatment efficacy, complication rates, and long-term outcomes, the analysis provides robust, statistically significant evidence favoring operative intervention in certain pediatric scenarios.

The methodology employed in this meta-analysis adhered rigorously to established guidelines for systematic reviews, employing comprehensive database searches, precise inclusion criteria centered on age groups under 18, and standardized definitions for treatment failure and major complications. Advanced statistical techniques were utilized for pooled effect size estimation, heterogeneity assessment, and sensitivity analyses to ensure the validity and reliability of findings. This methodological rigor offers a high degree of confidence in the conclusions drawn.

In clinical practice, this evolving evidence base mandates that pediatricians and pediatric surgeons engage in nuanced, individualized treatment planning discussions with families. The elevated risks associated with nonoperative pathways demand transparent communication about the potential for subsequent interventions, prolonged morbidity, and the risk-benefit calculus that underpins surgical versus conservative management choices. As such, shared decision-making becomes paramount, respecting patient-specific factors and family preferences.

The implications of this study reverberate beyond immediate clinical choices, prompting reconsideration of current guidelines and protocols in pediatric surgical care. Institutions may need to reconsider conservative management algorithms where the risk profiles illuminated by this meta-analysis reveal unacceptable failure rates. Future clinical guidelines might incorporate these findings to refine patient stratification and risk assessment frameworks.

Moreover, this research calls attention to the unique pathophysiological and biomechanical characteristics of the pediatric gastrointestinal tract. The developmental and immunological distinctions between children and adults suggest that treatment efficacies and tolerances to nonoperative care may differ substantially, warranting age-specific clinical pathways that depart from adult-centered models.

Further investigations will be critical to delineate which subgroups within the pediatric population are most susceptible to adverse outcomes with nonoperative care. Genetic, immunologic, and microbiome profiling could emerge as frontiers for personalized medicine approaches aimed at optimizing treatment responsiveness and minimizing complications. This could also include the development of predictive models integrating clinical and biological markers.

Technological advances, such as minimally invasive surgical techniques and enhanced perioperative care, might also mitigate the risks historically associated with operative management. These innovations could shift the risk-benefit balance further in favor of surgery by reducing recovery times, procedural morbidity, and hospital stays, thus strengthening the argument for surgical intervention as a viable first-line option.

From a healthcare systems perspective, the economic and resource allocation considerations must also be addressed. Treatment failures and complications from nonoperative management can lead to increased hospital readmissions, prolonged care, and escalated costs. In contrast, strategically employed operative management, despite initial resource utilization, may ultimately reduce the burden on pediatric healthcare infrastructure.

This meta-analysis also sheds light on the critical role of family dynamics and the psychological dimensions influencing treatment decisions. Understanding family values, anxieties concerning surgery, and cognitive processing of risks plays a pivotal role in adherence to prescribed treatment pathways. Thus, multidisciplinary approaches involving surgeons, pediatricians, psychologists, and social workers could enhance treatment outcomes through tailored support.

The study was spearheaded by Dr. Isabella Faria, with correspondence available at imdefrei@utmb.edu, reflecting a collaboration among experts dedicated to refining pediatric surgical care through evidence-based medicine. Presented at the prestigious American College of Surgeons Clinical Congress 2025, the findings are poised to influence clinical norms and patient care standards widely.

In summary, this landmark meta-analysis redefines the therapeutic landscape for managing pediatric intestinal conditions by highlighting the superior safety profile and efficacy of operative interventions relative to conservative management within the first year post-treatment. This paradigm shift will likely catalyze further research, guideline revisions, and clinical adaptations that prioritize long-term pediatric health outcomes.

Subject of Research: Pediatric and adolescent management of acute intestinal conditions, focusing on treatment failure and complication rates in operative versus nonoperative approaches.

Article Title: Not provided in the source content.

News Publication Date: Not specified (study presented at American College of Surgeons Clinical Congress 2025).

Web References: Not provided.

References: (doi:10.1001/jamapediatrics.2025.4091)

Image Credits: Not provided.

Keywords: Cecum, Pediatrics, Medical treatments, Adolescents, Children, Decision making, Surgery, Metaanalysis, Acute infections, Family

Acetaminophen, widely marketed as Tylenol® in the United States and paracetamol in other regions, has remained the most widely recommended and consumed analgesic and antipyretic for pregnant women globally. Historically classified as the go-to option due to its purportedly minimal side effects, its ubiquitous presence in prenatal care protocols has gone largely unquestioned until now. The Mount Sinai-led research team’s meta-analytic review reveals that this perception may be overly simplistic, with accumulating evidence indicating that prenatal acetaminophen exposure correlates with heightened risks for autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD).

Central to the study’s strength is the deployment of the Navigation Guide Systematic Review methodology, a rigorous framework specifically designed for environmental health research. Unlike conventional literature reviews, this method evaluates each study’s internal validity, potential biases, and overall evidence strength with a critical lens. Metrics such as selective outcome reporting, attrition bias, and confounding variables were meticulously assessed. This comprehensive synthesis enabled the research team to discern patterns that individual studies alone had been too limited to conclusively identify, thereby producing a more robust collective analysis.

Dr. Diddier Prada, the study’s lead investigator and Assistant Professor of Population Health Science and Policy at Mount Sinai, emphasized the clinical importance of the research findings. He noted that higher-quality studies within the dataset consistently demonstrated a statistically significant association between prenatal acetaminophen use and an increased prevalence of neurodevelopmental disorders. “Given how common acetaminophen use is during pregnancy, even a marginal elevation in risk could translate into a substantial public health concern,” Dr. Prada maintained. This observation places a spotlight on the delicate balance obstetric healthcare providers must strike between managing maternal symptoms and ensuring fetal safety.

Delving into the biological underpinnings, the study examines plausible mechanistic pathways by which acetaminophen could influence fetal brain development. Notably, acetaminophen readily crosses the placental barrier, exposing the developing fetus to its pharmacologic effects. Within this context, hypotheses center around induced oxidative stress, endocrine disruption, and epigenetic modifications as convergent factors that may interfere with normal neurodevelopmental trajectories. These disruptions to the in utero environment are posited to impair neuronal differentiation and circuit formation, setting the stage for later behavioral and cognitive challenges.

While the research stops short of establishing direct causality, the reinforced correlations warrant reconsideration of current prenatal pharmaceutical practices. The authors caution that indiscriminate use of acetaminophen during pregnancy—particularly when alternatives exist or non-pharmacological interventions are feasible—could unintentionally contribute to an increased societal burden of developmental disorders. This perspective urges a more cautious, time-restricted, and medically supervised application of acetaminophen for managing maternal pain and fever.

Importantly, the study underscores that pregnant individuals should not unilaterally discontinue acetaminophen without professional guidance. As emphasized by Dr. Prada, uncontrolled maternal fever and pain bear inherent risks for both mother and child, advocating carefully calibrated treatment decisions. Healthcare providers are thus encouraged to engage in nuanced risk-benefit discussions with patients, promote judicious use of acetaminophen, and prioritize exploration of non-pharmacological remedies where appropriate.

The implications of this research ripple across multiple domains, with substantial bearings on public health policy, clinical recommendations, and patient education frameworks. Rising incidence rates of autism and ADHD globally compound the urgency for reevaluating pharmacological safety during critical windows of neurodevelopment. Healthcare systems may need to refine educational materials and protocols, ensuring that practitioners and expectant mothers alike are fully apprised of emerging evidence and best practices.

Moreover, the study adds momentum to the call for intensified pharmaceutical innovation targeting safer analgesic and antipyretic options suitable for pregnancy. The complex interplay between effective symptom management and fetal neuroprotection remains an unresolved clinical challenge demanding prioritization in drug development pipelines. Identification of compounds that circumvent the mechanistic pitfalls identified with acetaminophen could transform prenatal care paradigms.

Collaborative efforts underpinning this research span prestigious institutions, including the University of California, Los Angeles; the University of Massachusetts Lowell; and Harvard T.H. Chan School of Public Health. Such cross-disciplinary cooperation underscores the multidimensional nature of environmental health studies and the imperative for diverse expertise to dissect the nuanced interrelations between medication use and developmental outcomes.

This pioneering work, published in the journal BMC Environmental Health, represents a paradigm shift emphasizing methodological rigor and comprehensive data integration. It equips clinicians and policymakers with refined evidence to guide safer medication practices in pregnancy, catalyzing reforms in guidelines and expanding avenues for future investigation.

As the medical community digests these findings, the study provokes crucial ethical and practical questions regarding how best to evolve prenatal care amid mounting evidence of environmental and pharmaceutical influences on the developing brain. It exemplifies the potential of systematic review methodologies not only to synthesize existing knowledge but to illuminate hitherto obscured risks inherent to widely adopted health interventions.

In conclusion, while acetaminophen’s analgesic and antipyretic properties have long made it a mainstay in managing pregnancy-related discomforts, this compelling new evidence invites a paradigm reconsideration. Careful, evidence-informed strategies must now navigate the complexities of alleviating maternal symptoms without compromising neurodevelopmental health, marking a seminal advance in both environmental health research and clinical obstetrics.

Subject of Research: Not applicable

Article Title: Evaluation of the evidence on acetaminophen use and neurodevelopmental disorders using the Navigation Guide methodology

News Publication Date: August 14, 2025

Web References: Not provided

References: Not provided

Image Credits: Not provided

Keywords: Autism